| 常用名 | rel-N-[(1R,2S)-2-苯基环丙基]-4-哌啶胺 | CAS号 | 1431368-48-7 |
|---|---|---|---|
| 价格 | ¥需询单/1kg ¥需询单/1g ¥需询单/1mg | 纯度 | 98.0% |
| 备货期 | 需询单 | 库存 | 询单 |
| 产品详情(用途,包装等)
用途: GSK-LSD1 is a LSD1 inhibitor. GSK-LSD1 reduces food intake and body weight, and improves insulin sensitivity and glycemic control in mouse models of obesity. GSK-LSD1 also ameliorates NAFLD. GSK-LSD1 inhibits SARS-CoV-2-triggered cytokine release in COVID-19 PBMCs. GSK-LSD1 also inhibits cancer growth and metastasis[1][2][3]. 物理化学性质: CAS号:1431368-48-7 常用中文名:rel-N-[(1R,2S)-2-苯基环丙基]-4-哌啶胺 常用英文名:GSK-LSD1 2HCL 分子式:C14H20N2 分子量:216.322 密度:1.1±0.1 g/cm3 沸点:347.4±42.0 °C at 760 mmHg 熔点:N/A 闪点:206.0±19.7 °C 储存条件:2-8°C |